Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1247 (miR-1247) is a small, non-coding RNA molecule that functions as a gene regulator by binding to specific target mRNAs and repressing their translation or promoting their degradation[3]. It has been shown to directly target key genes such as the transcription factor SOX9, essential for cartilage formation and function, indicating a role in skeletal and cartilage biology[1]. In addition, miR-1247 acts as a tumor suppressor in pancreatic cancer by targeting the regulator of chromosome condensation 2 (RCC2), and its expression is frequently downregulated in cancer through epigenetic silencing by promoter hypermethylation, suggesting diagnostic and therapeutic relevance in oncology[2]. Its biological activities include regulation of cell differentiation, proliferation, apoptosis, and maintenance of cell identity across various tissues.
Direct translational repression of target mRNA (e.g., SOX9, RCC2)[1][2] Epigenetic silencing by DNA methylation (causes downregulation of miR-1247 in tumors)[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1247 (miR-1247).